Status:
RECRUITING
The Determinants of Fertility Preservation in TRANSgender Patients.
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Fertility Preservation
Transgender
Eligibility:
All Genders
18-60 years
Brief Summary
The study is monocentric, retrospective, non-interventional and does not involve human subjects. The main objective is to compare the profiles of transgender patients who undergo fertility preservati...
Detailed Description
This study aims to assess the determinants of fertility preservation (FP) among transgender patients at the University Regional Hospital Center (CHRU) of Nancy. The secondary objective was to establis...
Eligibility Criteria
Inclusion
- Transgender patients who consulted the Assisted Reproductive Technology centre of the Nancy Regional University Hospital, between 1st January 2020 and 30th June 2023. The consultations occurred for the start of transition care, for follow-up or for a parenting project for transgender patients.
Exclusion
- minors
- patients under guardianship or under tutelage
Key Trial Info
Start Date :
September 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT06074796
Start Date
September 25 2023
End Date
April 1 2024
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre AMP Maternité Régionale de Nancy
Nancy, France, 54000